Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-04-21 @ 4:46 PM
Study NCT ID:
NCT02527434
Status:
COMPLETED
Last Update Posted:
2023-11-15
First Post:
2015-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Tremelimumab in Patients With Advanced Solid Tumors
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-12
First Submit QC Date:
None
Study First Post Date:
2015-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-02-13
Results First Submit QC Date:
None
Results First Post Date:
2019-03-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-14
Last Update Post Date:
2023-11-15
Last Update Post Date Type:
ACTUAL